US20070098706A1
University of Texas System
A purified polypeptide includes an NADPH oxidase cytosolic cofactor polypeptide NOXA1 or P67 phox having a C-terminal SH3 domain insertion mutation of at least three consecutive amino acids positioned between PEDL and GIFPK motifs of said SH3 domain so as to reduce activity of the purified …